A British High Court case filed by victims of blood clots caused by the AstraZeneca Oxford COVID-19 vaccine has the media buzzing over a company admission to a serious blood clotting condition called VITT or vaccine induced thrombocytopenic purpura.
AstraZeneca Concedes Blood Clotting Concerns from Oxford/AstraZeneca (ChAdOx1-S) Vaccine
Written by Peter A. Mccullough, MD, MPH